Navigation Links
ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases
Date:6/24/2009

BLACK MOUNTAIN, N.C., June 24 /PRNewswire/ -- ALP Life Sciences, LLC (Company) today announced the Nanoveson(TM) patent has been filed and the Nanoveson(TM) whitepaper is available at www.ALPLifeSciences.com/wp. After completing initial research, the Company is pursuing clinical trials and FDA regulatory approval of Nanoveson(TM) as a prescription drug treatment for non-alcoholic fatty liver disease (NAFLD).

Over 60 million adult Americans suffer from NAFLD and these numbers are rising rapidly. There is no FDA approved NAFLD treatment. NAFLD is a global health crisis. NAFLD is also associated with the metabolic syndrome and other life threatening diseases. NAFLD is known to progress to more advanced liver diseases such as non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis and liver cancer.

Nanoveson(TM) is a novel approach to treating and diagnosing liver diseases and comorbid diseases utilizing the principles of Applied Lipid Polymorphism, which includes a revolutionary application of nanobiotechnology in the area of self-organizing lipid membranes. Nanoveson(TM) therapy utilizes only natural compounds. The therapy triggers liver triglyceride remodeling into bile phospholipids and lipid membrane fusion and aggregation in the intestines. Molecular compounds including biliary phospholipids, arachidonic acid metabolites, cholesterol, methyl metabolites, phthalate esters, and other compounds sequestered in vesicle membranes are expected to be a rich source of disease state biomarkers. Nanoveson(TM) also has the potential to provide extensive support to the life sciences industry in the area of drug metabolism testing.

Research has demonstrated that enterohepatic circulation is the mechanism that maintains quantitative whole body homeostasis of arachidonic acid. T
'/>"/>

SOURCE ALP Life Sciences, LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dow AgroSciences, World Wide Wheat Agree to Collaborate on Wheat
2. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
3. Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery
4. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
5. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
6. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
7. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
8. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
9. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
10. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., MORRISTOWN, N.J., Nov. 6 /PRNewswire-FirstCal...a leading specialty pharmaceutical company, announ... chief executive officer, will provide an overview...t Suisse 18th Annual Healthcare Conference on Wedn...ard Time. ,, This presentation will be webcast ...
(Date:11/6/2009)..., DETROIT, Nov. 6 Car... CPD ) has launched ketorolac tromethamine ophthal... the US Food and Drug Administration (FDA) for Sun...for generic Acular® ophthalmic solution on th...ngth of ketorolac is therapeutically equivalent to...
(Date:11/6/2009)..., HOPKINTON, Mass., Nov. 6 Face...ired all of the assets of Archus Orthopedics. The ...ion in product offerings, intellectual property an...tion. "This is a win for patients suffering from l...esident & CEO, Geoff Pardo. "This consolidati...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Facet Solutions Acquires Archus Orthopedics 2Trimming the fat boosts blood recovery after marrow transplant 48507 1Trimming the fat boosts blood recovery after marrow transplant 48507 2Versartis presents positive preclinical data on 2 product candidates at ENDO 09 8794 1Versartis presents positive preclinical data on 2 product candidates at ENDO 09 8794 2Spencers Benefits Reports COBRA Survey Finds Recession Takes Hold 3A More Were Eligible Fewer Signed Up Costs Stay High 48502 1Spencers Benefits Reports COBRA Survey Finds Recession Takes Hold 3A More Were Eligible Fewer Signed Up Costs Stay High 48502 2Spencers Benefits Reports COBRA Survey Finds Recession Takes Hold 3A More Were Eligible Fewer Signed Up Costs Stay High 48502 3Spencers Benefits Reports COBRA Survey Finds Recession Takes Hold 3A More Were Eligible Fewer Signed Up Costs Stay High 48502 4
...J. Fox,Foundation for Parkinson,s Research awarded...peed development of effective therapies for the,un...of Parkinson,s disease.,Patients often report thes...ve function (the ability to formulate, sequence, a...and anxiety; and behavioral issues,including probl...
...onascent, Inc.,( http://www.neuronascent.com ) ann... from multiple sources to further the development ...mer,s disease, depression and,ischemia. Neuronasce...epartment of Business and Economic Development Cha...tnerships in collaboration with University,of Mary...
Other Medicine Technology:Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 2Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 3Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease 4Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs 2
(Date:11/7/2009)... Brown: "Faithful Catholics have a responsibility ...egotiate the status quo." ,, WASHINGTON, Nov....gue president Judie Brown released the following s...ill support Speaker Nancy Pelosi,s Affordable Heal...mendment preserving the status quo for abortion is...
(Date:11/7/2009)...GO, Nov. 7 The Public Relations Society of Americ...llow on Diane Gage Lofgren, senior vice president ...r Permanente, tonight at a ceremony at PRSA,s 2009...g inducted into the PRSA College of Fellows is one...aid Michael Herman, APR, SAGE, Fellow PRSA, and 20...
(Date:11/7/2009)... In the current economic climate,...losely and are only spending money on what that th...ight loss surgeon David D. Kim believes that it&r... and women to receive treatment to improve their h...y affordable to patients in this tough economy by ...
(Date:11/6/2009)..., Nov. 6 Recently a Narconon of Georgia graduate ...ence with prescription drug abuse. The special rep... drug addiction . In the report Andrew shared ... should be done to prevent prescription drug abuse... knew I opened my eyes to my father on top of me g...
(Date:11/6/2009)...IS, Nov. 6 Centene Corporation (NYSE: CNC ) toda...ealthcare conferences over the next few weeks. ,, ... Care Conference, to be held November 11-13, 2009,..., Centene will present Wednesday, November 11th at...rested parties may access Centene,s presentation a...
Breaking Medicine News(10 mins):Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Narconon Drug Rehab of Georgia Graduate Featured on Local News 2Health News:Centene Corporation to Present at Upcoming Healthcare Conferences 2
...ire/ -- The American Academy of Actuaries appl...cial Security,s and Medicare,s long-term financial... bipartisan solutions to ensure both programs, via... Par k s , the president of the American Acade...
...ng population of breast cancer survivors ages, man...esses like diabetes and heart disease, and they,ll...ith the late effects of cancer therapies they rece... the post-cancer care they receive from their prim...
...ing to the Technical University of Catalonia (UPC)...hosen by the European Space Agency (ESA) to design...gravity conditions. They will be monitoring how in...edicine from UAB, and Arnau Rabadn, a postgraduate...
...chnologies, Inc. (OTC Bulletin Board: VHGI) today ...vantage of the availability of nearly 20 billion d...e Appropriations Committee,s $825 billion economic...alyst in jump-starting the adoption of any technol...
...Jan. 21 ,Ultra Clean Technology (Ultra Clean Holdi...aq: FEIC ) announced today they have signed a Gl...ll provide hosted manufacturing services,in the FE...companies are targeting the first quarter of 2009 ...
... Inc. ("Atkins"), one of the best known weight-man...s or ingredients marketed under the Atkins Advanta...in any way by the recent peanut butter recall dire...he companies currently at the focus of the FDA inv...
Other Medicine News:Health News:Actuaries Laud New President's Medicare and Social Security Message, Call for Bipartisan Solution 2Health News:Penn study: Breast cancer survivors call for more 'survivorship care' from primary care physicians 2Health News:Penn study: Breast cancer survivors call for more 'survivorship care' from primary care physicians 3Health News:Students from UAB and UPC will experiment under microgravity conditions at the ESA 2Health News:Students from UAB and UPC will experiment under microgravity conditions at the ESA 3Health News:VirtualHealth Technologies, Inc. Unveils Strategy to Leverage $20 Billion Federal Health IT Proposal 2Health News:VirtualHealth Technologies, Inc. Unveils Strategy to Leverage $20 Billion Federal Health IT Proposal 3Health News:Ultra Clean Technology to Manufacture Products for FEI Company 2Health News:Ultra Clean Technology to Manufacture Products for FEI Company 3Health News:Ultra Clean Technology to Manufacture Products for FEI Company 4Health News:Atkins(TM) Nutritionals Products Are Not Affected by FDA Peanut Butter Recall 2
... super-light polypropylene mesh which offers an ex...n is reduced considerably. Optilene Mesh LP is the...repair procedures. It perfectly conforms,to anat...y Optilene Mesh LP adapts to the movements of the ...
...orming Plug is a mesh plug to treat large or recur...nd femoralhernias. The self-expanding plug perfect...remilene Mesh Self-Forming Plug is a preshaped mes... corresponds with all properties of Premilene Mesh...
...system of the Applied Fiberoptics headlight delive...on. There are six models to choose from, with both... from 15 mm to 120 mm., ,Each Applied Fiberopt... quality fiberoptic cables and lightsources. Each ...
... vascular clamps can be associated with vessel dam...ges its elasticity, causing increased clamping pre...y be associated with endothelial damage. Dingo cla...ts elasticity and unlike stainless steel clamps, d...
Medicine Products: